Ngwaahịa
-
Pulegone
Pulegone bụ ketone monoterpene na-emekarị nke a na-achọta na mmanụ dị mkpa nke ụdị mint dị ka pennyroyal, spearmint, na pepemint. A na-eji ya dị ka ihe na-esi ísì ụtọ, ihe na-esi ísì ụtọ, na nke etiti na ọgwụ na ọgwụ kemịkal. Emepụtara API Pulegone anyị site na usoro mmịpụta a nụchara anụcha na usoro nchacha iji hụ na ịdị ọcha dị elu, nkwụsi ike na nnabata na ụkpụrụ nchekwa na ịdị mma dị mkpa.
-
Etelcalcetide
Etelcalcetide bụ peptide calcimimetic sịntetik ejiri maka ọgwụgwọ hyperparathyroidism nke abụọ (SHPT) na ndị ọrịa nwere ọrịa akụrụ na-adịghị ala ala (CKD) na hemodialysis. Ọ na-arụ ọrụ site na ịgbalite calcium-sensing receptor (CaSR) na mkpụrụ ndụ parathyroid, si otú ahụ na-ebelata ọkwa hormone parathyroid (PTH) ma na-emeziwanye metabolism nke ịnweta. Emepụtara API Etelcalcetide dị ọcha anyị site na njikọ peptide siri ike (SPPS) n'okpuru ọnọdụ GMP, dabara adaba maka usoro injectable.
-
Bremelanotide
Bremelanotide bụ peptide sịntetik na melanocortin receptor agonist mepụtara maka ọgwụgwọ ọrịa agụụ mmekọahụ hypoactive (HSDD) na ụmụ nwanyị premenopausal. Ọ na-eme site na ịgbalite MC4R na sistemu ụjọ nke etiti iji kwalite agụụ mmekọahụ na mkpali. A na-arụpụta API Bremelanotide dị ọcha site na njikọ peptide siri ike (SPPS) n'okpuru ụkpụrụ ịdị mma siri ike, dabara maka usoro injectable.
-
Etelcalcetide Hydrochloride
Etelcalcetide Hydrochloride bụ ọgwụ peptide nke sitere na calcimimetic sịntetik ejiri maka ọgwụgwọ hyperparathyroidism nke abụọ (SHPT) na ndị ọrịa nwere ọrịa akụrụ na-adịghị ala ala (CKD) na hemodialysis. Ọ na-arụ ọrụ site na ịgbalite ndị na-ahụ maka calcium-sensing (CaSR) na gland parathyroid, si otú ahụ na-ebelata ọkwa parathyroid hormone (PTH) ma na-eme ka calcium-phosphate nguzozi. A na-emepụta API Etelcalcetide anyị site na njikọ peptide dị ọcha ma na-agbaso ụkpụrụ ịdịmma mba ụwa maka ngwaahịa injectable ọkwa ọkwa ọgwụ.
-
Semaglutide 10mg 15mg 20mg 30mg maka ọgwụgwọ nke ụdị ọrịa shuga 2.
Aha: Semaglutide Injection Powder
Steeti: Lyophilized ntụ ntụ Peptide
Ọdịdị: White ntụ ntụ
Ọkwa: Ọkwa ahụike
Ịdị ọcha: 99%
Nha: 10mg, 15mg, 20mg, 30mg
nchịkwa: Injection subcutaneous
Uru: Ịgwọ ọrịa shuga mellitus
-
30mg 99% Ọcha Semaglutide Arọ Mbelata Peptide Fitness Injection Peptides
Aha: Peptide na-ebelata ibu
Ịdị ọcha:> 99%
Agba: Ọcha
Steeti: Ghichaa ntụ ntụ a mịrị amị
nchịkwa: Injection subcutaneous
Nkọwa: 10mg, 15mg, 20mg, 30mg
Uru: oke ibu
-
Semaglutide Lyophilized Powder Vial 20mg Hazie 99% Peptide ịdị ọcha dị arọ
Aha: semaglutide injection Peptides
Ịdị ọcha: 99%
Ọkọlọtọ Ọkwa: Ọkwa ọgwụỌdịdị: Lyophilized Powder Peptide
Agba: Ọcha
Nkọwa: 10mg, 15mg, 20mg, 30mg
nchịkwa: Injection subcutaneous
Uru: oke ibu
-
Tirzepatide Lyophilized High Purity 99% Peptide Powder 60mg kwa vial maka ọrịa shuga na ọnwụ dị arọ.
Aha: Tirzepatide ntụ ntụ ntụ
Ịdị ọcha: 99%
Uru: Ịgwọ ọrịa shuga, Mbelata ibu
nchịkwa: Injection subcutaneous
Nha: 10mg, 15mg, 20mg, 30mg, 60mg
Ọdịdị: White Lyophilized ntụ ntụ
-
Tirzepatide ntụ ntụ maka ịgbanye maka mbelata ibu 30mg kwa Vial ọcha 99%
Aha: Tirzepatide ntụ ntụ ntụ
Ịdị ọcha: 99%
Nha: 30mg
Mmiri: 3.0%
Ọdịdị: White Lyophilized ntụ ntụ
Solubility: kwekọrọ
HPLC ldentification: kwekọrịtara
Endotoxins nje: Ihe na-erughị 5 EU/mg
MS njirimara: 4810.6
Uru: Mbelata ibu
-
A na-eji Dibutyl Phthalate eme ihe dị ka pasticizer maka Nitrocellulose
Aha: Dibutyl phthalate
Nọmba CAS: 84-74-2
Usoro ihe omimi: C16H22O4
Ibu ibu: 278.34
Nọmba EINECS: 201-557-4
Ebe mgbaze: -35C (ọkụ)
Ebe esi mmiri: 340C (ọkụ)
Njupụta: 1.043 g/mL na 25 Celsius C (ọkụ.)
-
Diethylene Glycol Dibenzoate 120-55-8
Aha: Diethylene glycol dibenzoate
Nọmba CAS: 120-55-8
Usoro ihe omimi: C18H18O5
Arọ molikula: 314.33
Nọmba EINECS: 204-407-6
Ebe mgbaze: 24°C
Ebe esi mmiri: 235-237 °C7 mm Hg (ọkụ.)
Njupụta: 1.175 g/mL na 25 Celsius (ọkụ)
-
Diisononyl phthalate DINP 28553-12-0
Aha: Diisononyl phthalate
Nọmba CAS: 28553-12-0
Usoro ihe omimi: C26H42O4
Ibu ibu: 418.61
Nọmba EINECS: 249-079-5
Ebe mgbaze: -48°
Ebe esi mmiri: bp5 mm Hg 252°
Njupụta: 0.972 g/mL na 25 Celsius C (ọkụ.)